LTBP4 and colorectal carcinoma: Notably, no loss-of-function variants (e.g. stop-gain, frameshift, start-loss or canonical splice-site mutations) were identified in any patient cohort, limiting the ability to draw conclusions about the contribution of LTBP4 germline mutations to CRC predisposition.